This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Gwenn Danet-Desnoyers: Innovator in Cancer Treatment
Introduction
Gwenn Danet-Desnoyers is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer treatment, particularly in the development of innovative therapies for acute myeloid leukemia. With a total of 2 patents, his work is paving the way for new treatment options.
Latest Patents
Gwenn's latest patents focus on the use of anti-CD38 antibodies for the treatment of acute myeloid leukemia. The present invention relates to methods of treatment that utilize these antibodies, showcasing his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Gwenn Danet-Desnoyers is currently associated with Janssen Biotech, Inc., where he continues to work on groundbreaking research. His expertise in the field has positioned him as a key player in the development of innovative cancer therapies.
Collaborations
Some of his notable coworkers include Parul Doshi and Cedric Dos Santos, who contribute to the collaborative efforts in research and development at Janssen Biotech, Inc.
Conclusion
Gwenn Danet-Desnoyers is a dedicated inventor whose work in cancer treatment is making a significant impact. His innovative approaches and collaborations are essential in the fight against acute myeloid leukemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile